Asthma Treatment Standard Set

Asthma Treatment Standard Set
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
Cay10008640-1 1 each -

3 - 10 Werktage*

77,00 €
 
The Cayman Asthma Treatment Standard Set contains three potent, selective Cysteinyl Leukotriene... mehr
Produktinformationen "Asthma Treatment Standard Set"
The Cayman Asthma Treatment Standard Set contains three potent, selective Cysteinyl Leukotriene (CysLT) 1 receptor antagonists (10 mg each) currently used clinically for the treatment of asthma. Zafirlukast and Montelukast (sodium salt), sold under the trade names Accolate and Singulair, respectively, are used for the treatment of asthma as well as for the symptoms associated with allergic rhinitis. Pranlukast, sold under the trade name Ultair, was the first CysLT receptor antagonist marketed for the treatment of asthma. In addition to these three CysLT1 receptor antagonists, the asthma pak also includes Zileuton, which is supplied free of charge. Zileuton is a reversible 5-LO inhibitor that was approved in 1997 for the prevention and treatment of asthma in the USA, but was withdrawn by Abbott Laboratories in 2003.
Hersteller: Cayman Chemical
Hersteller-Nr: 10008640-1

Eigenschaften

Anwendung: CysLT1 receptor antagonist

Datenbank Information

Handhabung & Sicherheit

Lagerung: -20°C
Versand: -20°C (International: -20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Asthma Treatment Standard Set"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen